Tatva Chintan Pharma Chem Ltd
NSE:TATVA
Tatva Chintan Pharma Chem Ltd
NSE:TATVA
Price:
1 177.6
INR
2.4%
Market Closed
Market Cap:
₹27.5B
Cash Flow Statement
Cash Flow Statement
Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Ltd
Currency: INR
| Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||
| Net Income |
448
|
467
|
436
|
247
|
76
|
246
|
|
| Depreciation & Amortization |
96
|
178
|
256
|
263
|
277
|
322
|
|
| Other Non-Cash Items |
112
|
107
|
30
|
(7)
|
17
|
33
|
|
| Cash Taxes Paid |
93
|
76
|
99
|
98
|
45
|
51
|
|
| Cash Interest Paid |
84
|
122
|
65
|
11
|
13
|
17
|
|
| Change in Working Capital |
(377)
|
393
|
259
|
(108)
|
(122)
|
(344)
|
|
| Cash from Operating Activities |
278
N/A
|
1 145
+312%
|
980
-14%
|
394
-60%
|
247
-37%
|
258
+4%
|
|
| Investing Cash Flow | |||||||
| Capital Expenditures |
(2 031)
|
(1 734)
|
(1 285)
|
(1 164)
|
(763)
|
(902)
|
|
| Other Items |
1 020
|
77
|
80
|
174
|
110
|
(14)
|
|
| Cash from Investing Activities |
(1 011)
N/A
|
(1 657)
-64%
|
(1 205)
+27%
|
(991)
+18%
|
(653)
+34%
|
(916)
-40%
|
|
| Financing Cash Flow | |||||||
| Net Issuance of Common Stock |
0
|
12
|
12
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
506
|
(779)
|
(1 548)
|
(448)
|
225
|
679
|
|
| Cash Paid for Dividends |
0
|
0
|
0
|
(47)
|
(47)
|
0
|
|
| Other |
(128)
|
1 866
|
1 841
|
(43)
|
(13)
|
(18)
|
|
| Cash from Financing Activities |
378
N/A
|
1 101
+191%
|
305
-72%
|
(539)
N/A
|
166
N/A
|
661
+299%
|
|
| Change in Cash | |||||||
| Effect of Foreign Exchange Rates |
(1)
|
(2)
|
(1)
|
(1)
|
1
|
1
|
|
| Net Change in Cash |
(357)
N/A
|
587
N/A
|
79
-86%
|
(1 136)
N/A
|
(239)
+79%
|
3
N/A
|
|
| Free Cash Flow | |||||||
| Free Cash Flow |
(1 753)
N/A
|
(589)
+66%
|
(305)
+48%
|
(770)
-153%
|
(516)
+33%
|
(644)
-25%
|
|
Switch to:
Switch to:
See Also
Discover More
